newsfilter
← Latest News
Business Wire·

ESTEVE Launches INBRIJA® in Spain

Acorda Therapeutics, Inc. (NASDAQ:ACOR) announced that Esteve Pharmaceuticals, S.A. has launched INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Spain. INBRIJA is indicated in the EU for the intermittent